Scholarlink

<p>Carbapenem-resistant Enterobacteriaceae (CRE) are critical priority pathogens due to their resistance to carbapenems, the last-resort antibiotics, and their rapid spread in healthcare facilities. The study investigates the epidemiological and molecular characteristics of CRE isolates in the Jazan region, Saudi Arabia. Clinical specimens were collected from patients admitted to Jazan General Hospital between December 2023 and May 2024. Identification of the isolates was done by the VITEK 2 system, and their susceptibility to antibiotics was determined on the MicroScan WalkAway platform according to the EUCAST guidelines. The E-test was used to confirm the CRE isolates. Molecular detection of carbapenemase genes (<i>bla</i><sub>IMP</sub>, <i>bla</i><sub>VIM</sub>, <i>bla</i><sub>NDM</sub>, <i>bla</i><sub>KPC</sub> and <i>bla</i><sub>OXA-48</sub>) was conducted using the GeneXpert Carba-R assay using the GeneXpert®. A total of 426 Enterobacterial clinical isolates were collected from patients; among them, 53 (12.4%) were phenotypically found to be CRE; among such isolates, 14 (26.4%) were found to be carbapenemase-positive Enterobacteriaceae (CPE), and 39 (73.6%) were carbapenemase-negative Enterobacteriaceae (CNE). Among the CPE strains, <i>Klebsiella pneumoniae</i> was the predominant organism (42.9%), followed by <i>Escherichia coli</i> (28.6%), <i>Enterobacter cloacae</i> (21.4%), and <i>Serratia marcescens</i> (7.1%). Molecular analysis revealed a high prevalence of the <i>bla</i> <sub>NDM</sub> gene (71.4%), with <i>bla</i><sub>OXA-48</sub> detected in 42.9% of isolates. The <i>bla</i><sub>VIM</sub> was identified in only 7.1%, while neither the <i>bla</i><sub>KPC</sub> nor <i>bla</i><sub>IMP</sub> is detected. For the CNE strains, <i>K. pneumoniae</i> was most common (62%), of which 15% produced extended-spectrum β-lactamase (ESBL). The isolates were all highly resistant to penicillin and β-lactam/β-lactamase inhibitors, moderately susceptible to fluoroquinolone (33%) and aminoglycosides (49%), and most susceptible to tigecycline (79%). The <i>bla</i><sub>NDM</sub> was mainly found among ICU patients, while <i>bla</i><sub>OXA-48</sub> was most frequently identified among pediatric patients. The ICU admission with invasive devices, and prior broad-spectrum antibiotic exposure emerged as the main risk factors for the evolution of CPE. Multiple comorbidities; particularly malignancy, diabetes, and surgery; further increased vulnerability to CPE infections. Jazan city has a lower prevalence of CPE, while non-carbapenemase resistance is most predominant, reflecting regional epidemiological heterogeneity, which is important for regional stewardship and control.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Detection of New Delhi metallo-β-lactamase (blaNDM) and oxacillinase (blaOXA-48) genes among carbapenem-resistant Enterobacteriaceae (CRE) in Jazan Region, Saudi Arabia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月24日

查看全文
  • Soheir A. A. Hagras,
  • Gharieb S. El-Sayyad,
  • Marwa Yousry A. Mohamed,
  • Hani A. Ozbak,
  • Mahitab M. Wahby,
  • Sara Ahmed Eltigani,
  • Neamat Hanem M. I. Dorra,
  • Samar Elshahidy,
  • Mostafa A. Abdel-Maksoud,
  • Salman Alrokayan,
  • Hassan A. Rudayni,
  • Yasser Q. Majrabi

摘要

Carbapenem-resistant Enterobacteriaceae (CRE) are critical priority pathogens due to their resistance to carbapenems, the last-resort antibiotics, and their rapid spread in healthcare facilities. The study investigates the epidemiological and molecular characteristics of CRE isolates in the Jazan region, Saudi Arabia. Clinical specimens were collected from patients admitted to Jazan General Hospital between December 2023 and May 2024. Identification of the isolates was done by the VITEK 2 system, and their susceptibility to antibiotics was determined on the MicroScan WalkAway platform according to the EUCAST guidelines. The E-test was used to confirm the CRE isolates. Molecular detection of carbapenemase genes (blaIMP, blaVIM, blaNDM, blaKPC and blaOXA-48) was conducted using the GeneXpert Carba-R assay using the GeneXpert®. A total of 426 Enterobacterial clinical isolates were collected from patients; among them, 53 (12.4%) were phenotypically found to be CRE; among such isolates, 14 (26.4%) were found to be carbapenemase-positive Enterobacteriaceae (CPE), and 39 (73.6%) were carbapenemase-negative Enterobacteriaceae (CNE). Among the CPE strains, Klebsiella pneumoniae was the predominant organism (42.9%), followed by Escherichia coli (28.6%), Enterobacter cloacae (21.4%), and Serratia marcescens (7.1%). Molecular analysis revealed a high prevalence of the bla NDM gene (71.4%), with blaOXA-48 detected in 42.9% of isolates. The blaVIM was identified in only 7.1%, while neither the blaKPC nor blaIMP is detected. For the CNE strains, K. pneumoniae was most common (62%), of which 15% produced extended-spectrum β-lactamase (ESBL). The isolates were all highly resistant to penicillin and β-lactam/β-lactamase inhibitors, moderately susceptible to fluoroquinolone (33%) and aminoglycosides (49%), and most susceptible to tigecycline (79%). The blaNDM was mainly found among ICU patients, while blaOXA-48 was most frequently identified among pediatric patients. The ICU admission with invasive devices, and prior broad-spectrum antibiotic exposure emerged as the main risk factors for the evolution of CPE. Multiple comorbidities; particularly malignancy, diabetes, and surgery; further increased vulnerability to CPE infections. Jazan city has a lower prevalence of CPE, while non-carbapenemase resistance is most predominant, reflecting regional epidemiological heterogeneity, which is important for regional stewardship and control.